Feifei Qi
Impact in
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral gastroenteritis research and epidemiology
- SARS-CoV-2 detection and testing
- Animal Science and Zoology top 5%
- Animal Virus Infections Studies
Papers in
-
- Enzyme Catalysis and Immobilization 3
-
- SARS-CoV-2 and COVID-19 Research 8
- COVID-19 Clinical Research Studies 7
- SARS-CoV-2 detection and testing 3
- Co-authors
- Chuan Qin (7 shared papers)Linlin Bao (11 shared papers)Shuwen Liu (1 shared paper)Meiqin Liu (1 shared paper)Wei Xu (1 shared paper)Qiaoshuai Lan (1 shared paper)Fei Sun (1 shared paper)Zheng‐Li Shi (1 shared paper)
- Journals
- Journal of Medical Virology (2 papers)Viruses (2 papers)Advanced Materials (1 paper)BMC Infectious Diseases (1 paper)Journal of Asian Natural Products Research (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Feifei Qi
30 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Infectious Diseases 889
- Animal Science and Zoology 118
- Computational Theory and Mathematics 170
- Microbiology 66
- Immunology 208
Countries citing papers authored by Feifei Qi
This map shows the geographic impact of Feifei Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Qi more than expected).
Fields of papers citing papers by Feifei Qi
This network shows the impact of papers produced by Feifei Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Qi. The network helps show where Feifei Qi may publish in the future.
Co-authors
The 25 scholars most cited alongside Feifei Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion Hit paper breakdown → | 2020 | 978 |
| 2 | 2014 | 84 | |
| 3 | 2018 | 72 | |
| 4 | 2019 | 69 | |
| 5 | 2013 | 52 | |
| 6 | 2021 | 52 | |
| 7 | 2021 | 43 | |
| 8 | 2016 | 37 | |
| 9 | 2017 | 33 | |
| 10 | 2018 | 32 | |
| 11 | 2021 | 32 | |
| 12 | 2019 | 20 | |
| 13 | 2014 | 19 | |
| 14 | 2022 | 17 | |
| 15 | 2023 | 16 | |
| 16 | 2016 | 15 | |
| 17 | 2022 | 13 | |
| 18 | 2020 | 11 | |
| 19 | 2022 | 10 | |
| 20 | 2014 | 5 |
About Feifei Qi
Feifei Qi is a scholar working on Molecular Biology, Infectious Diseases, Pharmacology, Epidemiology and Immunology, having authored 33 papers that have together received 1.6k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (7 papers), Microbial Natural Products and Biosynthesis (5 papers), Long-Term Effects of COVID-19 (4 papers), Influenza Virus Research Studies (4 papers), Respiratory viral infections research (4 papers), Enzyme Catalysis and Immobilization (3 papers) and SARS-CoV-2 detection and testing (3 papers). The work is most often cited by research in Infectious Diseases (889 citations), Animal Science and Zoology (118 citations), Computational Theory and Mathematics (170 citations), Microbiology (66 citations) and Immunology (208 citations). Feifei Qi has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Chuan Qin, Linlin Bao, Shuwen Liu, Meiqin Liu, Wei Xu, Qiaoshuai Lan, Fei Sun, Zheng‐Li Shi, Shibo Jiang and Chao Wang. Their work appears in journals such as Journal of Medical Virology, Viruses, Advanced Materials, BMC Infectious Diseases and Journal of Asian Natural Products Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.